Anne L. Holleran

Array ( [id] => 5642638 [patent_doc_number] => 20060281093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Erbb receptor methods and kits for monitoring chemotherapy resistance' [patent_app_type] => utility [patent_app_number] => 10/567702 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17177 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281093.pdf [firstpage_image] =>[orig_patent_app_number] => 10567702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347863 [patent_doc_number] => 20040248139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Eit-6, a polypeptide encoded by an estrogen regulated gene' [patent_app_type] => new [patent_app_number] => 10/494930 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14756 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248139.pdf [firstpage_image] =>[orig_patent_app_number] => 10494930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9285710 [patent_doc_number] => 08642036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Treatment with anti-ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 10/909998 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 17511 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10909998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996714 [patent_doc_number] => 20050136492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Affinity labeling of enzymes for detection of enzyme activity level in living cells' [patent_app_type] => utility [patent_app_number] => 10/872818 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10474 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136492.pdf [firstpage_image] =>[orig_patent_app_number] => 10872818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082616 [patent_doc_number] => 20050047996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Phosphatase associated with metastasis' [patent_app_type] => utility [patent_app_number] => 10/868658 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7911 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20050047996.pdf [firstpage_image] =>[orig_patent_app_number] => 10868658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033113 [patent_doc_number] => 20050031622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Treatment and diagnosis of cancer using inositolphosphoglycans antagonists' [patent_app_type] => utility [patent_app_number] => 10/870562 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6828 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031622.pdf [firstpage_image] =>[orig_patent_app_number] => 10870562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834226 [patent_doc_number] => 20060246056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Immunotherapy of rectal cancer' [patent_app_type] => utility [patent_app_number] => 10/558166 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4727 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246056.pdf [firstpage_image] =>[orig_patent_app_number] => 10558166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276627 [patent_doc_number] => 20040236078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Method for making humanized antibodies' [patent_app_type] => new [patent_app_number] => 10/835641 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35651 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20040236078.pdf [firstpage_image] =>[orig_patent_app_number] => 10835641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7457120 [patent_doc_number] => 20040197333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Use of TGF-beta antagonists to inhibit tumor cell formation or progression' [patent_app_type] => new [patent_app_number] => 10/830647 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6839 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197333.pdf [firstpage_image] =>[orig_patent_app_number] => 10830647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832819 [patent_doc_number] => 20080131366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Folate Receptor Gene Modulation For Cancer Diagnosis And Therapy' [patent_app_type] => utility [patent_app_number] => 10/549662 [patent_app_country] => US [patent_app_date] => 2004-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19012 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131366.pdf [firstpage_image] =>[orig_patent_app_number] => 10549662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325213 [patent_doc_number] => 20040138160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Preventive/therapeutic method for cancer' [patent_app_type] => new [patent_app_number] => 10/475990 [patent_app_country] => US [patent_app_date] => 2004-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 37489 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138160.pdf [firstpage_image] =>[orig_patent_app_number] => 10475990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880524 [patent_doc_number] => 20060029606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Method for use of IGF-binding protein for selective sensitization of target cells in vivo' [patent_app_type] => utility [patent_app_number] => 10/778636 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8630 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029606.pdf [firstpage_image] =>[orig_patent_app_number] => 10778636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305868 [patent_doc_number] => 20040116330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Preventive/therapeutic method for cancer' [patent_app_type] => new [patent_app_number] => 10/475815 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36899 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116330.pdf [firstpage_image] =>[orig_patent_app_number] => 10475815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425397 [patent_doc_number] => 20040161426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Use of IL-6 antagonists in combination with steroids to enhance apoptosis' [patent_app_type] => new [patent_app_number] => 10/759674 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7252 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161426.pdf [firstpage_image] =>[orig_patent_app_number] => 10759674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694103 [patent_doc_number] => 20060154250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Novel compositions and methods in cancer' [patent_app_type] => utility [patent_app_number] => 10/539228 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 57117 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154250.pdf [firstpage_image] =>[orig_patent_app_number] => 10539228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7353341 [patent_doc_number] => 20040249140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Transcription factors that regulate normal and malignant cell growth' [patent_app_type] => new [patent_app_number] => 10/725811 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10917 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249140.pdf [firstpage_image] =>[orig_patent_app_number] => 10725811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823426 [patent_doc_number] => 07405061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Antigen PIPA and antibodies that bind thereto' [patent_app_type] => utility [patent_app_number] => 10/713248 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26490 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405061.pdf [firstpage_image] =>[orig_patent_app_number] => 10713248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034179 [patent_doc_number] => 20050032689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Methods for treatment or diagnosis of disease or disorders associated with an APB domain' [patent_app_type] => utility [patent_app_number] => 10/704128 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14627 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032689.pdf [firstpage_image] =>[orig_patent_app_number] => 10704128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333241 [patent_doc_number] => 20040131611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Combination therapy using anti-egfr antibodies and anti-hormonal agents' [patent_app_type] => new [patent_app_number] => 10/476478 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14348 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131611.pdf [firstpage_image] =>[orig_patent_app_number] => 10476478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7341361 [patent_doc_number] => 20040191229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase' [patent_app_type] => new [patent_app_number] => 10/682178 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 21558 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191229.pdf [firstpage_image] =>[orig_patent_app_number] => 10682178 [rel_patent_id] =>[rel_patent_doc_number] =>)